Dr. Hoehn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
New York
New York, NY 10019
Education & Training
University of Texas M D Anderson Cancer CenterPost-Doctoral Fellowship, Hematopathology, 2010 - 2012
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Pathology-Anatomic and Clinical, 2006 - 2010
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 2005 - 2006
Johannes Gutenberg University of Mainz Faculty of MedicineClass of 2004
Certifications & Licensure
NY State Medical License 2014 - 2026
PA State Medical License 2009 - 2018
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 21 citationsDaratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN.Peter M. Voorhees, Cesar Rodriguez, Brandi Reeves, Nitya Nathwani, Luciano J. Costa
Blood Advances. 2021-02-23 - 413 citationsDaratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialPeter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach, Douglas W. Sborov, Brandi Reeves
Blood. 2020-08-20 - 7 citationsEffects of High- and Low-LET Radiation on Human Hematopoietic System Reconstituted in Immunodeficient MiceDaniela Hoehn, Monica Pujol-Canadell, Erik F. Young, Geo Serban, Igor Shuryak
Radiation Research. 2018-12-06
Abstracts/Posters
- Daratumumab (DARA) Maintenance Therapy Improves Depth of Response and Results in Durable Progression-free Survival (PFS) Following DARA plusCyclophosphamide, Bortezomi...Robert M. Rifkin, Jason Melear, Edward Faber, William I. Bensinger, John M. Burke, Mohit Narang, Don Stevens, Sriya Gunawardena, Daniela Hoehn, Yana Lutska, Keqin Qi, ..., ASH 2019, Orlando, 12/9/2019
- Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnose...Daniela Hoehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
